Abnormal cervical cytology in pregnancy: A laboratory and clinical dermatologic perspective

Journal of Perinatal and Neonatal Nursing

Volumn 14, Issue 1, 2000, Pages 52-62

  Huff, Beth Colvin ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cervical cytology; Colposcopy; Dysplasia; Pap test; Pregnancy

Indexed keywords

FEMALE; HUMAN; MATERNAL CARE; METHODOLOGY; NURSING; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; UTERINE CERVIX TUMOR; VAGINA SMEAR;

FEMALE; HUMANS; MATERNAL-CHILD NURSING; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034208111     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200006000-00005     Document Type: Review

References (29)

1. Copeland L, Landon M. Malignant diseases in pregnancy. Gabbe SG, Niebyl JR, Simpson JL, eds. In: Obstetrics: Normal and Problem Pregnancies. 3rd ed. New York, NY: Churchill Livingstone; 1996:1155-1181.
2. Campion MJ, Sedlacek TV. Colposcopy in pregnancy. In: Wright VC, ed. Obstetrics and Gynecology Clinics of North America: Contemporary Colposcopy. Philadelphia, Pa: WB Saunders; 1993:153-163.
3. Cervical Cancer. NIH Consensus Statement. 1996;14(1):1-38.
4. Shingleton HM, Patrick RL, Johnston WW, Smith RA. The current status of the Papanicolaou smear. CA Cancer J Clin. 1995;45(5):305-320.
5. McGee JE. Management of cervical dysplasia in pregnancy. Nurse Pract. 1987; 12(3):34-42.
6. Hild-Mosley KA, Lindblade JA, Julian TM. The management of cervical mucus in obtaining a Papanicolaou smear. J Lower Genital Tract Dis. 1997;1(1):1-3.
7. Cox JT. ASCCP practice guidelines: management issues related to quality of the smear. J Lower Genital Tract Dis. 1997; 1(2):100-106.
8. Stillson T, Knight AL, Elswick RK. The effectiveness and safety of two cervical cytologic techniques during pregnancy. J Family Prac. 1997;45(2):159-163.
9. Paraiso MFR, Brady K, Helmchen R, Roat TW. Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women. Obstet Gynecol. 1994;84(4):539-543.
10. Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol. 1997;90(2):278-284.
11. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. J Am Med Assoc. 1994;271(23):1866-1869.
12. Mashburn J, Scharbo-DeHaan M. A clinician's guide to Pap smear interpretation. Nurse Pract. 1997;22(4):115-143.
13. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York, NY: Springer-Verlag; 1994.
14. American College of Obstetricians and Gynecologists. Absence of endocervical cells on a Pap test. ACOG Committee Opinion 153. Washington, DC: ACOG; 1995.
15. McDermott-Webster M. The HPV epidemic. Am J Nurs. 1999;99(3):24L-24N.
16. Apgar BS, Zoschnick LB. Triage of the abnormal Papanicolaou smear in pregnancy. Primary Care. 1998;25(2):483-503.
17. Petry KU, Scheefel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer. 1994;57(6):836-840.
18. Lauver DR, Baggot A, Kruse K. Women's experiences in coping with abnormal Papanicolaou results and follow-up colposcopy. J Obstet Gynecol Neonatal Nurs. 1999;28(3):283-290.
19. Tomaino-Brunner C, Freda MC, Damus K, Runowicz CD. Can precolposcopy education increase knowledge and decrease anxiety? J Obstet Gynecol Neonatal Nurs. 1998;27(6):636-646.
20. Foulks MJ. The Papanicolaou smear: its impact on the promotion of women's health. J Obstet Gynecol Neonatal Nurs. 1998;27(4):367-373.
21. Campion MJ, Ferris DG, di Paola FM, Reid R. Modern Colposcopy: A Practical Approach. Augusta, Ga: Educational Systems; 1991.
22. Connor JP. Noninvasive cervical cancer complicating pregnancy. Obstet Gynecol Clin North Am. 1998;25(2):331-342.
23. Baldauf JJ, Dreyfus M, Ritter J. Benefits and risks of directed biopsy in pregnancy. J Lower Genital Tract Dis. 1997;1(4):214-220.
24. Cristoforoni PM, Gerbaldo DL, Philipson J, et al. Management of the abnormal Papanicolaou smear during pregnancy: lessons for quality improvement. J Lower Genital Tract Dis. 1999;3(4):225-230.
25. Shivvers SA, Miller DS. Preinvasive and invasive breast and cervical cancer prior to or during pregnancy. Clin Perinatol. 1997;24(2):369-389.
26. Robinson WR, Webb S, Tirpack J, Degefu S, O'Quinn AG. Management of cervical intraepithelial neoplasia during pregnancy with LOOP excision. Gynecol Oncol. 1997;64(1):153-155.
27. Ahdoot D, Van Nostrand KM, Nguyen NJ, et al. The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. Am J Obstet Gynecol. 1998;178(6):1116-1120.
28. Yost NP, Santoso JT, McIntire DD, Iliya FA. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol. 1999;93(3):359-362.
29. Harper DM, Roach MSI. Cervical intraepithelial neoplasia in pregnancy. J Family Pract. 1996;42(1):79-83.